LASIK治疗成人单眼近视性屈光参差性弱视的疗效观察

Laser in situ Keratomileusis for Adult Monocular Myopic Anisometropic Amblyopia

目的探讨准分子激光原位角膜磨镶术(laser in situ keratomileusis,LASIK)治疗成人单眼近视性屈光参差性弱视的效果和安全性。方法前瞻性观察47例成人单眼近视性屈光参差性弱视眼的LASIK手术后1、6和12个月时的裸眼视力,并与该眼术前最佳矫正视力进行比较。结果所有患者术后1、6和12个月时弱视眼的裸眼视力(uncorrected visual acuity,UCVA)均等于或大于术前的最佳矫正视力(the best corrected visual acuity,BCVA),并且随术后时间的延长UCVA有逐渐提高的趋势,且未发现手术并发症,所有患者均对手术结果表示满意。术后1、6和12个月时弱视眼的UCVA高于术前BCVA的分别为37、38和38只眼,约占术眼的78.7%、80.8%、80.8%。结论 LASIK手术治疗成人单眼近视性屈光参差性弱视安全、有效。

Objective To analyze the efficiency and safety of laser in situ keratomileusis（LASIK） for adult monocular myopic anisometropic amblyopia. Methods Forty-seven patients who were diagnosed as adult monocular myopic anisometropic amblyopia were treated with LASIK.The best corrected visual acuity（BCVA） before LASIK and the uncorrected visual acuity（UCVA） 1,6 and 12 months after LASIK were compared. ResultsAll UCVA in 1,6 and 12 months after LASIK increased or equaled to BCVA before LASIK.No complications were found and all the patients were satisfied with the effect. ConclusionsLASIK is an effective and safe treatment for adult monocular myopic anisometropic amblyopia.